Xtandi

Xtandi Overdosage

enzalutamide

Manufacturer:

Astellas Pharma

Distributor:

DKSH
Full Prescribing Info
Overdosage
There is no antidote for enzalutamide. In the event of an overdose, treatment with enzalutamide should be stopped and general supportive measures initiated taking into consideration the half-life of 5.8 days. Patients may be at increased risk of seizures following an overdose.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in